Publications
Showing records 1 - 20 (of 36)
Publication: JournalArticle (Originalarbeit in einer wissenschaftlichen Zeitschrift)
ID
Author
Year
Title
Publisher
2832800 Bontognali, S.; Pless, M.; Brutsche, M. H.; Fischer, C.; Rochlitz, C.; Buess, M.
2013
Analysis of the EGFR mutation status in head and neck squamous cell carcinoma before treatment with Gefitinib
Onkologie
4407716 Conen, Katrin L.; Fischer, Natalie; Hofbauer, Günther F. L.; Shafaeddin-Schreve, Bahar; Winterhalder, Ralph; Rochlitz, Christoph; Zippelius, Alfred
2014
Cetuximab in metastatic squamous cell cancer of the skin: a Swiss case series
Dermatology
1196976 Dummer, Reinhard; Rochlitz, Christoph; Velu, Thierry; Acres, Bruce; Limacher, Jean-Marc; Bleuzen, Pascal; Lacoste, Gisèle; Slos, Philippe; Romero, Pedro; Urosevic, Mirjana
2008
Intralesional adenovirus-mediated interleukin-2 gene transfer for advanced solid cancers and melanoma
Molecular therapy
4407711 Ehrbar, V.; Urech, C.; Alder, J.; Harringer, K.; Zanetti Dallenbach, R.; Rochlitz, C.; Tschudin, S.
2016
Decision-making about fertility preservation—qualitative data on young cancer patients’ attitudes and needs
Archives of Women's Mental Health
1193332 Gross,M; Obermann,E; Weinand,K; Zimmermann,F; Rochlitz,C
2008
Der aktuelle Stand beim invasiven, nicht hämatogen metastasierten Mammakarzinom
InfoOnkologie
1195473 Güth, Uwe; Huang, Dorothy Jane; Dirnhofer, Stephan; Rochlitz, Christoph; Wight, Edward
2009
Distant metastatic breast cancer as an incurable disease : a tenet with a need for revision
The cancer journal : the official journal of the American Radium Society
4407709 Hammann, Felix; Gotta, Verena; Conen, Katrin; Medinger, Michael; Cesana, Philipp; Rochlitz, Christoph; Taegtmeyer, Anne B.
2017
Pharmacokinetic interaction between taxanes and amiodarone leading to severe toxicity
British Journal of Clinical Pharmacology
2819350 Huggenberger, Harriet; Ehrbar, Verena; Eichelberger, D.; Roth, Binia; Gaab, Jens; Wössmer, Brigitta; Rochlitz, Christoph; Alder, Judith
2014
Online-Unterstützung für Familien mit einem krebskranken Elternteil
Onkologische Pflege; Konferenz onkologischer Kranken- und Kinderkrankenpflege (KOK)
1193767 Huober, Jens; Baumann, Michael; Rochlitz, Christoph; Aebi, Stefan; Güth, Uwe; von Moos, Roger; Müller, Andreas; von Rohr, Lukas; Widmer, Isabelle; Thürlimann, Beat
2011
Trastuzumab treatment beyond progression in advanced breast cancer : patterns of care in six Swiss breast cancer centers
Oncology
1023048 Imhof, Anna; Brunner, Philippe; Marincek, Nicolas; Briel, Matthias; Schindler, Christian; Rasch, Helmut; Mäcke, Helmut R; Rochlitz, Christoph; Müller-Brand, Jan; Walter, Martin A
2011
Response, survival, and long-term toxicity after therapy with the radiolabeled somatostatin analogue [90Y-DOTA]-TOC in metastasized neuroendocrine cancers
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
1195458 Iten, Fabienne; Muller, Beat; Schindler, Christian; Rasch, Helmut; Rochlitz, Christoph; Oertli, Daniel; Maecke, Helmut R.; Muller-Brand, Jan; Walter, Martin A.
2009
[(90)Yttrium-DOTA]-TOC response is associated with survival benefit in iodine-refractory thyroid cancer: long-term results of a phase 2 clinical trial
Cancer
4407710 Laubli, H.; Tzankov, A.; Juskevicius, D.; Degen, L.; Rochlitz, C.; Stenner-Liewen, F.
2016
Lenalidomide monotherapy leads to a complete remission in refractory B-cell post-transplant lymphoproliferative disorder
Leukemia & Lymphoma
2832801 Mamot, Christoph; Ritschard, Reto; Wicki, Andreas; Küng, Willy; Schuller, Jan; Herrmann, Richard; Rochlitz, Christoph
2012
Immunoliposomal delivery of doxorubicin can overcome multidrug resistance mechanisms in EGFR-overexpressing tumor cells
Journal of drug targeting
2832802 Mamot, Christoph; Ritschard, Reto; Wicki, Andreas; Stehle, Gregor; Dieterle, Thomas; Bubendorf, Lukas; Hilker, Christoph; Deuster, Stefanie; Herrmann, Richard; Rochlitz, Christoph
2012
Tolerability, safety, pharmacokinetics, and efficacy of doxorubicin-loaded anti-EGFR immunoliposomes in advanced solid tumours: a phase 1 dose-escalation study
The Lancet oncology
1635005 Marincek, Nicolas; Jörg, Ann-Catherine; Brunner, Philippe; Schindler, Christian; Koller, Michael T; Rochlitz, Christoph; Müller-Brand, Jan; Maecke, Helmut R; Briel, Matthias; Walter, Martin A
2013
Somatostatin-based radiotherapy with [90Y-DOTA]-TOC in neuroendocrine tumors : long-term outcome of a phase I dose escalation study
Journal of translational medicine
4373873 Meier-Abt, F.; Bentires-Alj, M.; Rochlitz, C.
2015
Breast Cancer Prevention: Lessons to be Learned from Mechanisms of Early Pregnancy–Mediated Breast Cancer Protection
Cancer Research
3886346 Orleth, Annette; Mamot, Christoph; Rochlitz, Christoph; Ritschard, Reto; Alitalo, Kari; Christofori, Gerhard; Wicki, Andreas
2016
Simultaneous targeting of VEGF-receptors 2 and 3 with immunoliposomes enhances therapeutic efficacy
Journal of Drug Targeting
4407708 Pagani, Olivia; Klingbiel, Dirk; Ruhstaller, Thomas; Nole, Franco; Eppenberger-Castori, Serenella; Oehlschlegel, Christian; Bernhard, Jürg; Brauchli, Peter; Hess, Dagmar; Mamot, Christoph; Munzone, Elisabetta; Pestalozzi, Bernhard C.; Rabaglio, Manuela; Aebi, Stefan; Ribi, Karin; Rochlitz, Christoph; Rothgiesser, Karin; Thürlimann, Beat; von Moos, Roger; Zaman, Khalil; Goldhirsch, Aron; Swiss Group for Clinical Cancer, Research
2017
Do all patients with advanced HER2 positive breast cancer need upfront-chemo when receiving trastuzumab? Randomized phase III trial SAKK 22/99
Annals of Oncology
2832804 Rajski, M.; Vogel, B.; Baty, F.; Rochlitz, C.; Buess, M.
2012
Global gene expression analysis of the interaction between cancer cells and osteoblasts to predict bone metastasis in breast cancer
PLoS ONE
2832805 Rajski, Michal; Zanetti-Dällenbach, Rosanna; Vogel, Brigitte; Herrmann, Richard; Rochlitz, Christoph; Buess, Martin
2010
IGF-I induced genes in stromal fibroblasts predict the clinical outcome of breast and lung cancer patients
BMC medicine
Showing records 1 - 20 (of 36)
